Kilitch Drugs India Ltd consolidated Q1 FY2023-24 PAT at Rs. 3.35 crore

Kilitch Drugs (India) Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 37.1195 crores during the period ended June 30, 2023 as compared to Rs. 46.4974 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 3.3571 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 3.5637 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 2.15 for the period ended June 30, 2023 as compared to Rs. 2.29 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 37.1195 crs	₹46.4974 crs	-20.17%
Net Profit	₹3.3571 crs	₹3.5637 crs	-5.80%
EPS	₹2.15	₹2.29	-6.11%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 37.1195 crores during the period ended June 30, 2023 as compared to Rs.34.4241 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.3.3571 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.2.0862 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.2.15 for the period ended June 30, 2023 as compared to Rs.1.34 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 37.1195 crs	₹34.4241 crs	7.83%
Net Profit	₹3.3571 crs	₹2.0862 crs	60.92%
EPS	₹2.15	₹1.34	60.45%

Shares of Kilitch Drugs (India) Limited was last trading in BSE at Rs. 195.05 as compared to the previous close of Rs. 197.55. The total number of shares traded during the day was 1711 in over 11 trades.

The stock hit an intraday high of Rs. 199.95 and intraday low of 195.05. The net turnover during the day was Rs. 338471.00.

Source : Equity Bulls

Keywords

KilitchDrugsIndia Q1FY24 ResultUpdate